Prevalence of Rare and Common Bleeding Disorders in Kurdistan Province of Iran

Author(s):
Akbar DorgalalehAkbar Dorgalaleh1,*, Jamal Rashid PanahJamal Rashid Panah2, Bijan VarmaghaniBijan Varmaghani3, Peyman BeigiPeyman Beigi4, Abbas AhmadiAbbas Ahmadi5
1Department of Hematology abd Blood Transfusion, School of Allied Medical Sciences, Iran University of Medical Sciences, Tehran
2Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran
3Tehran Hear Center, Tehran University of Medical Sciences, Tehran, Iran
4Department of Hematology and Blood Transfusion, Tarbiat Modares University, Tehran, Iran
5Cellular and Molecular Research Center, Research Institute for Health Development, Kurdistan University of Medical Sciences, Sanandaj, Iran
*Corresponding Author: Department of Hematology abd Blood Transfusion, School of Allied Medical Sciences, Iran University of Medical Sciences, Tehran Email: [email protected]

Journal of Cellular & Molecular Anesthesia:Vol. 4, issue 4; e149593
Published online:Mar 24, 2020
Article type:Original Articles
How to Cite:Dorgalaleh A, Rashid Panah J, Varmaghani B, Beigi P, Ahmadi A. Prevalence of Rare and Common Bleeding Disorders in Kurdistan Province of Iran. J Cell Mol Anesth. 2019;4(4):e149593. doi: https://doi.org/10.22037/jcma.v4i4.29074

Abstract

Background: Congenital bleeding disorders (CBD) are a group of coagulopathies with different clinical and laboratory features. The prevalence of these disorders in different parts of the world is variable. Iran as a country with a high rate of parental consanguinity has a high rate of CBDs. This study was to report the prevalence of these disorders in Kurdistan province, west of Iran.Methods and materials: This descriptive study was conducted on patients suspected of a congenital bleeding disorder referred to hemophilia center of this province for evaluation of underlying bleeding diathesis. Diagnosis and classification of disorders were made by routine and specific laboratory tests.Results: Out of 107 patients, 65.4% affected by common bleeding disorders (hemophilia A and B), 23.4% affected by rare bleeding disorders (RBDs) and 11.2% had inherited platelet disorders. Factor VII deficiency (64%) was the most common RBDs and 9 patients had von Willebrand disease. Out of three patients with inherited platelet disorders, two had Glanzmann thrombasthenia.Conclusion: CBD pattern though has similar patterns with total pattern of the country, some of the inherited platelet disorders are more common in Kurdish province. Determination of prevalence and distribution of these disorders can improve health system planning and resource allocation.Keywords: Congenital bleeding disorders, Rare bleeding disorders, Common bleeding disorders, inherited platelet disorders

References

  • 1.
    References are in the PDF file of the article.

Copyright

© 2019, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.

Similar Articles

31
Jan
2018

Bleeding Episodes Among Patients with Congenital Fibrinogen Disorders, a Study On 12 New Iranian Patients

Majid Naderi,
Parvin Rahamani,
Shaban Alizadeh,
Hengam Razavi,
Akbar Dorgalaleh

Naderi M, Rahamani P, Alizadeh S, Razavi H, Dorgalaleh A. Bleeding Episodes Among Patients with Congenital Fibrinogen Disorders, a Study On 12 New Iranian Patients. J Cell Mol Anesth. 2018;3(1):e150274. doi: https://doi.org/10.22037/jcma.v3i1.19754

14
Jan
2021

Complete Genotype and Clinical Phenotype of Hemophilia B: A Study on Iranian Patients

marzieh shakouri,
Maryam Sadat Hosseini,
Akbar Dorgalaleh,
Minoo Shahidi,
Farhad Zaker

shakouri M, Hosseini MS, Dorgalaleh A, Shahidi M, Zaker F. Complete Genotype and Clinical Phenotype of Hemophilia B: A Study on Iranian Patients. J Cell Mol Anesth. 2021;6(1):e150285. doi: https://doi.org/10.22037/jcma.v6i1.33722

1
Jan
2017

Genetic Risk Factors for Inhibitor Development in Patients with Hemophilia and Rare Bleeding Disorders

Taregh Bamedi,
Ghazaleh Dadashizadeh,
Afsaneh Sarabandi,
Shadi Tabibian,
Mahmood Shams,
Akbar Dorgalaleh

Bamedi T, Dadashizadeh G, Sarabandi A, Tabibian S, Shams M, et al. Genetic Risk Factors for Inhibitor Development in Patients with Hemophilia and Rare Bleeding Disorders. J Cell Mol Anesth. 2017;2(1):e149529. doi: https://doi.org/10.22037/jcma.v2i1.14481

30
Apr
2012

Lack of Knowledge About Hepatitis C Infection Rates Among Patients With Inherited Coagulation Disorders in Countries Under the Eastern Mediterranean Region Office of WHO (EMRO): A Meta-Analysis

Seyed Moayed Alavian,
Seyed Hossein Aalaei-Andabili

Alavian S, Aalaei-Andabili S. Lack of Knowledge About Hepatitis C Infection Rates Among Patients With Inherited Coagulation Disorders in Countries Under the Eastern Mediterranean Region Office of WHO (EMRO): A Meta-Analysis. Hepat Mon. 2012;12(4):. doi: https://doi.org/10.5812/hepatmon.844

30
Sep
2008

Survey of the relationship between of thrombophilic factors and the rate and severity of bleeding in patients with severe hemophilia A

Mohammad Faranosh,
Navid Danayie,
raheb Ghorbani,
Mahbobeh Rahamani,
Mohammad Jazebi,
Tahere Shashani
,et al.

Faranosh M, Danayie N, Ghorbani R, Rahamani M, Jazebi M, et al. Survey of the relationship between of thrombophilic factors and the rate and severity of bleeding in patients with severe hemophilia A. koomesh. 2024;9(4):e152211. doi:

Download PDF446.15 KB

Crossmark

Crossmark

Checking

Share on
Cited by
Metrics

Ordering Reprints

Articles are published under the Creative Commons license stated on each article. No permission or royalty fee is required for uses permitted by that license. CCC handles optional bulk and customized reprint orders. Any quotation covers production and delivery services only, not copyright permission. > Request Reprints from CCC 

Search Relations

Author(s):

Related Articles